JioBook has appeared in a GeekBench listing, hinting towards its arrival soon. The listing also suggests that JioBook will feature Dimensity MT8788 chipset, 2GB of RAM and Android 11 OS. Here's everything we know about JioBook so far. After the launch of Jio Phone Next, Jio is now preparing to launch its first laptop, the JioBook. Looking at the brand's history of highly affordable phones, JioBook can be expected to be an entry-level laptop. The JioBook has now been spotted on GeekBench, revealing key details of the laptop. According to this, the laptop will be powered by the MediaTek MT8788 chipset. In addition, the JioBook is listed with 2GB of RAM and Android 11 OS. Reportedly, the JioBook scored 1,178 points in single-core and 4,246 points in multi-core tests. A previous leak suggests that JioBook will feature a 1366x768 pixels display. It was also said that the laptop would ship with a Snapdragon 665 chipset. The laptop was supposed to launch alongside the JioPhone Next, b...
New Delhi: India's all out count of COVID-19 cases flooded to 3,03,62,848 with 45,951 new diseases being accounted for in a day, while the recuperations have crossed 2.94 crores, as per the Union Health Ministry information refreshed on Wednesday.
The passing tally expanded to 3,98,454 with 817 new fatalities, the information refreshed at 8 am showed.
In the interim, India's Covaxin, created by Bharat Biotech in a joint effort with the Indian Council of Medical Research, adequately kills both Alpha and Delta variations of Covid, the US' National Institute of Health has said.
The NIH said consequences of two investigations of blood serum from individuals who had gotten Covaxin propose that the immunization produces antibodies that adequately kill the B.1.1.7 (Alpha) and B.1.617 (Delta) variations of SARS-CoV-2, first recognized in the UK and India, separately.
The top American wellbeing research organization, which has a background marked by solid logical cooperation with India, likewise said that an adjuvant created with financing from it has added to the achievement of the exceptionally effective Covaxin, which has been managed to approximately 25 million individuals till date in India and somewhere else.
Comments
Post a Comment